TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

3 Cutting-Edge Biotech Stocks That Can Double in Value
STOCKS

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

  • By Kinsey Grant
  • Mar 20, 2018 2:58 PM EDT
PRESS RELEASES

Acorda Therapeutics To Present At 39th Annual J.P. Morgan Health Care Conference

  • By Business Wire
  • Jan 12, 2021 4:07 PM EST
PRESS RELEASES

Acorda Therapeutics To Present At H.C. Wainwright BIOCONNECT Virtual Conference

  • By Business Wire
  • Jan 11, 2021 4:20 PM EST
PRESS RELEASES

Acorda Therapeutics Announces Completion Of One-for-Six Reverse Stock Split

  • By Business Wire
  • Dec 31, 2020 4:19 PM EST
PRESS RELEASES

Acorda Therapeutics Announces Adjournment Of Special Meeting Of Stockholders

  • By Business Wire
  • Jul 31, 2020 12:45 PM EDT
PRESS RELEASES

Acorda Second Quarter 2020 Update: Webcast/Conference Call Scheduled For August 4, 2020

  • By Business Wire
  • Jul 28, 2020 7:00 AM EDT
PRESS RELEASES

Acorda First Quarter 2020 Update: Webcast/Conference Call Scheduled For May 5, 2020

  • By Business Wire
  • Apr 28, 2020 7:00 AM EDT
PRESS RELEASES

Acorda Therapeutics To Present At Cowen Annual Health Care Conference

  • By Business Wire
  • Feb 24, 2020 7:00 AM EST
PRESS RELEASES

Acorda To Present Data At The 3rd Pan American Parkinson's Disease And Movement Disorders Congress

  • By Business Wire
  • Feb 12, 2020 7:00 AM EST
PRESS RELEASES

Acorda Fourth Quarter/Year End 2019 Update: Webcast/Conference Call Scheduled For February 13, 2020

  • By Business Wire
  • Jan 30, 2020 7:00 AM EST
PRESS RELEASES

Acorda To Present At The 38th Annual J.P. Morgan Healthcare Conference

  • By Business Wire
  • Jan 8, 2020 7:00 AM EST
3 Cutting-Edge Biotech Stocks That Can Double in Value
STOCKS

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

  • By Kinsey Grant
  • Mar 20, 2018 2:58 PM EDT
T-Mobile US, Take-Two Interactive, Owens Corning: 'Mad Money' Lightning Round
JIM CRAMER

T-Mobile US, Take-Two Interactive, Owens Corning: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Dec 15, 2017 6:49 AM EST
6 Can't Miss Tweets From TheStreet's Jim Cramer During the Market Meltdown
JIM CRAMER

Investors, Here's Your Big Chance: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Dec 15, 2017 6:31 AM EST
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Acorda Shares Down on FDA's 'Refusal to File' Letter - Biotech Movers

  • By Armie Margaret Lee
  • Aug 29, 2017 10:10 AM EDT
Takeda Pays $5.2 Billion for Leukemia Drug Maker Ariad, Ending Months of Takeout Speculation
MERGERS AND ACQUISITIONS

Acorda Stif Arms Investor's Demand for Sale

  • By William McConnell
  • Aug 7, 2017 8:24 PM EDT
3 Health Care Stocks to Own for 2017
HEALTH

Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks

  • By Armie Margaret Lee
  • Jul 14, 2017 4:11 PM EDT
Here Is Where Hedge Funds Are Finding Huge Success
STOCKS

Biotech Insider Just Loaded Up $234 Million Worth the Stock

  • By Roberto Pedone
  • Jun 21, 2017 2:18 PM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Adamis Shares Jump After FDA Approval For Epinephrine Pre-filled Syringe

  • By Armie Margaret Lee
  • Jun 16, 2017 9:52 AM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms

  • By Armie Margaret Lee
  • Jun 6, 2017 9:31 AM EDT
Biotech Premarket Movers: Cempra, Tesaro, Editas
HEALTH

Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda

  • By Armie Margaret Lee
  • May 1, 2017 9:45 AM EDT
French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug Data Reveal
STOCKS

Acorda Shares Fall in an Earnings Miss

  • By Adam Feuerstein
  • Apr 27, 2017 9:38 PM EDT
Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports
STOCKS

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

  • By Adam Feuerstein
  • Apr 27, 2017 4:07 PM EDT
Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports
VIDEO

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

  • By TheStreet Staff
  • Apr 27, 2017 8:50 AM EDT
Acorda CEO Risks All, Loses Nothing, When Drug Patent Strategy Backfires, Employees Fired
STOCKS

Acorda CEO Risks All, Loses Nothing, When Drug Patent Strategy Backfires, Employees Fired

  • By Adam Feuerstein
  • Apr 5, 2017 3:09 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.